Ghana pharmaceutical manufacturer targets ECOWAS market

Ghana’s Pharmaceutical Manufacturing Industry is nurturing the ambition to become the regional hub for the $250 million ECOWAS market.

Dr Michael Agyekum Addo, President of Ghana Pharmaceutical Manufacturing Association, who made this known in Accra on Tuesday said there was however the challenge of inadequate access to competitive investment capital and non-competitive pricing, high taxes, cost of freight, unclear and difficult payment terms and above all, different regulatory regimes in the sub-region.

 

Speaking at the opening of a multi-stakeholders’ roundtable on improving access to medicines through the development of the pharmaceutical industry, Dr Addo said the dream would reverse the dependence on pharmaceutical products from India and China.

 

NEPAD’s strategic document notes that Africa remains far too dependent on importation of essential drugs. Support to the industry will make drugs more affordable and accessible and increase industrial development”, he added.

The Minister of Health, Dr George Sipa Yankey in a speech read on his behalf said his sector Ministry recognized that Science and Technology played a pivotal role in meeting health related objectives on accessibility and availability of drugs, vaccines, diagnostic systems and improved access to medical information.

 

Source: AHU – Raymond Irambo

(Visited 1 times, 1 visits today)

Szóljon hozzá ehhez a cikkhez